Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Xrn2 | Rat | 1,2-dimethylhydrazine | affects expression | ISO | Xrn2 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine affects the expression of XRN2 mRNA | CTD | PMID:22206623 | Xrn2 | Rat | 17alpha-ethynylestradiol | affects expression | ISO | Xrn2 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of XRN2 mRNA | CTD | PMID:17555576 | Xrn2 | Rat | 17beta-estradiol | multiple interactions | ISO | XRN2 (Homo sapiens) | 6480464 | [Estradiol co-treated with Norethindrone Acetate] results in increased expression of XRN2 mRNA | CTD | PMID:22217510 | Xrn2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Xrn2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of XRN2 mRNA | CTD | PMID:21570461 | Xrn2 | Rat | 2,4,6-tribromophenol | decreases expression | ISO | XRN2 (Homo sapiens) | 6480464 | 2,4,6-tribromophenol results in decreased expression of XRN2 mRNA | CTD | PMID:31675489 | Xrn2 | Rat | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of XRN2 mRNA | CTD | PMID:21346803 | Xrn2 | Rat | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of XRN2 mRNA | CTD | PMID:21346803 | Xrn2 | Rat | 3,3',5,5'-tetrabromobisphenol A | increases expression | ISO | XRN2 (Homo sapiens) | 6480464 | tetrabromobisphenol A results in increased expression of XRN2 protein | CTD | PMID:31675489 | Xrn2 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | XRN2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Xrn2 | Rat | 4,4'-diaminodiphenylmethane | decreases expression | ISO | Xrn2 (Mus musculus) | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of XRN2 mRNA | CTD | PMID:18648102 | Xrn2 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Xrn2 (Mus musculus) | 6480464 | bisphenol S results in increased expression of XRN2 mRNA | CTD | PMID:39298647 | Xrn2 | Rat | aflatoxin B1 | increases expression | ISO | XRN2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of XRN2 mRNA | CTD | PMID:27153756 | Xrn2 | Rat | antirheumatic drug | decreases expression | ISO | XRN2 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of XRN2 mRNA | CTD | PMID:24449571 | Xrn2 | Rat | aristolochic acid A | decreases expression | ISO | XRN2 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of XRN2 mRNA | CTD | PMID:33212167 | Xrn2 | Rat | Aroclor 1254 | decreases expression | ISO | Xrn2 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of XRN2 mRNA | CTD | PMID:23650126 | Xrn2 | Rat | benzo[a]pyrene | increases methylation | ISO | XRN2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of XRN2 promoter | CTD | PMID:27901495 | Xrn2 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Xrn2 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of XRN2 mRNA | CTD | PMID:33754040 | Xrn2 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of XRN2 mRNA | CTD | PMID:25181051 | Xrn2 | Rat | bisphenol A | increases expression | ISO | XRN2 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of XRN2 protein | CTD | PMID:34186270 | Xrn2 | Rat | bisphenol A | decreases expression | ISO | XRN2 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of XRN2 protein | CTD | PMID:31675489|PMID:37567409 | Xrn2 | Rat | bisphenol A | decreases expression | ISO | Xrn2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of XRN2 mRNA | CTD | PMID:33221593 | Xrn2 | Rat | bisphenol AF | increases expression | ISO | XRN2 (Homo sapiens) | 6480464 | bisphenol AF results in increased expression of XRN2 mRNA | CTD | PMID:25912373 | Xrn2 | Rat | Bisphenol B | increases expression | ISO | XRN2 (Homo sapiens) | 6480464 | bisphenol B results in increased expression of XRN2 protein | CTD | PMID:34186270 | Xrn2 | Rat | bisphenol F | multiple interactions | ISO | XRN2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Xrn2 | Rat | bisphenol F | increases expression | ISO | Xrn2 (Mus musculus) | 6480464 | bisphenol F results in increased expression of XRN2 mRNA | CTD | PMID:38685157 | Xrn2 | Rat | Butylbenzyl phthalate | increases expression | ISO | Xrn2 (Mus musculus) | 6480464 | butylbenzyl phthalate results in increased expression of XRN2 mRNA | CTD | PMID:28392331 | Xrn2 | Rat | cadmium atom | multiple interactions | ISO | Xrn2 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of XRN2 more ... | CTD | PMID:37236586 | Xrn2 | Rat | cadmium dichloride | multiple interactions | ISO | Xrn2 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of XRN2 more ... | CTD | PMID:37236586 | Xrn2 | Rat | caffeine | affects phosphorylation | ISO | XRN2 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of XRN2 protein | CTD | PMID:35688186 | Xrn2 | Rat | CGP 52608 | multiple interactions | ISO | XRN2 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to XRN2 gene] | CTD | PMID:28238834 | Xrn2 | Rat | chloroprene | increases expression | EXP | | 6480464 | Chloroprene results in increased expression of XRN2 mRNA | CTD | PMID:23125180 | Xrn2 | Rat | choline | multiple interactions | ISO | Xrn2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... | CTD | PMID:20938992 | Xrn2 | Rat | copper atom | increases expression | ISO | Xrn2 (Mus musculus) | 6480464 | Copper results in increased expression of XRN2 mRNA | CTD | PMID:16629173 | Xrn2 | Rat | copper(0) | increases expression | ISO | Xrn2 (Mus musculus) | 6480464 | Copper results in increased expression of XRN2 mRNA | CTD | PMID:16629173 | Xrn2 | Rat | coumarin | decreases phosphorylation | ISO | XRN2 (Homo sapiens) | 6480464 | coumarin results in decreased phosphorylation of XRN2 protein | CTD | PMID:35688186 | Xrn2 | Rat | decabromodiphenyl ether | increases expression | ISO | XRN2 (Homo sapiens) | 6480464 | decabromobiphenyl ether results in increased expression of XRN2 protein | CTD | PMID:31675489 | Xrn2 | Rat | deguelin | increases expression | ISO | XRN2 (Homo sapiens) | 6480464 | deguelin results in increased expression of XRN2 mRNA | CTD | PMID:33512557 | Xrn2 | Rat | dexamethasone | multiple interactions | ISO | XRN2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Xrn2 | Rat | Dibutyl phosphate | affects expression | ISO | XRN2 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of XRN2 mRNA | CTD | PMID:37042841 | Xrn2 | Rat | dicrotophos | decreases expression | ISO | XRN2 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of XRN2 mRNA | CTD | PMID:28302478 | Xrn2 | Rat | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of XRN2 mRNA | CTD | PMID:25152437 | Xrn2 | Rat | diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of XRN2 mRNA | CTD | PMID:21551480 | Xrn2 | Rat | doxorubicin | increases expression | ISO | XRN2 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of XRN2 mRNA | CTD | PMID:29803840 | Xrn2 | Rat | enzyme inhibitor | multiple interactions | ISO | XRN2 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation more ... | CTD | PMID:23301498 | Xrn2 | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of XRN2 mRNA | CTD | PMID:24136188 | Xrn2 | Rat | folic acid | multiple interactions | ISO | Xrn2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... | CTD | PMID:20938992 | Xrn2 | Rat | FR900359 | affects phosphorylation | ISO | XRN2 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of XRN2 protein | CTD | PMID:37730182 | Xrn2 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of XRN2 mRNA | CTD | PMID:22061828 | Xrn2 | Rat | indometacin | multiple interactions | ISO | XRN2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Xrn2 | Rat | ivermectin | decreases expression | ISO | XRN2 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of XRN2 protein | CTD | PMID:32959892 | Xrn2 | Rat | L-methionine | multiple interactions | ISO | Xrn2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... | CTD | PMID:20938992 | Xrn2 | Rat | nickel sulfate | decreases expression | ISO | XRN2 (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of XRN2 mRNA | CTD | PMID:22714537 | Xrn2 | Rat | paracetamol | affects expression | ISO | Xrn2 (Mus musculus) | 6480464 | Acetaminophen affects the expression of XRN2 mRNA | CTD | PMID:17562736 | Xrn2 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of XRN2 mRNA | CTD | PMID:33387578 | Xrn2 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Xrn2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of XRN2 mRNA | CTD | PMID:36331819 | Xrn2 | Rat | phenobarbital | decreases expression | ISO | Xrn2 (Mus musculus) | 6480464 | Phenobarbital results in decreased expression of XRN2 mRNA | CTD | PMID:23091169 | Xrn2 | Rat | pirinixic acid | increases expression | ISO | Xrn2 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of XRN2 mRNA | CTD | PMID:23811191 | Xrn2 | Rat | rotenone | increases expression | ISO | XRN2 (Homo sapiens) | 6480464 | Rotenone results in increased expression of XRN2 mRNA | CTD | PMID:33512557 | Xrn2 | Rat | sodium arsenate | decreases expression | ISO | XRN2 (Homo sapiens) | 6480464 | sodium arsenate results in decreased expression of XRN2 protein | CTD | PMID:38348393 | Xrn2 | Rat | sodium arsenite | decreases expression | ISO | XRN2 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of XRN2 mRNA | CTD | PMID:22714537|PMID:39719251 | Xrn2 | Rat | sodium arsenite | increases expression | ISO | Xrn2 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of XRN2 mRNA | CTD | PMID:36209798 | Xrn2 | Rat | succimer | multiple interactions | ISO | Xrn2 (Mus musculus) | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of XRN2 mRNA | CTD | PMID:26378955 | Xrn2 | Rat | sunitinib | increases expression | ISO | XRN2 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of XRN2 mRNA | CTD | PMID:31533062 | Xrn2 | Rat | tamoxifen | affects expression | ISO | Xrn2 (Mus musculus) | 6480464 | Tamoxifen affects the expression of XRN2 mRNA | CTD | PMID:17555576 | Xrn2 | Rat | tetrachloromethane | increases expression | ISO | Xrn2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of XRN2 mRNA | CTD | PMID:31919559 | Xrn2 | Rat | tetraphene | increases expression | ISO | Xrn2 (Mus musculus) | 6480464 | benz(a)anthracene results in increased expression of XRN2 mRNA | CTD | PMID:26377693 | Xrn2 | Rat | titanium dioxide | decreases methylation | ISO | Xrn2 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of XRN2 gene; titanium dioxide results in decreased methylation more ... | CTD | PMID:35295148 | Xrn2 | Rat | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of XRN2 mRNA | CTD | PMID:33387578 | Xrn2 | Rat | triphenyl phosphate | affects expression | ISO | XRN2 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of XRN2 mRNA | CTD | PMID:37042841 | Xrn2 | Rat | troglitazone | decreases expression | ISO | Xrn2 (Mus musculus) | 6480464 | troglitazone results in decreased expression of XRN2 mRNA | CTD | PMID:28973697 | Xrn2 | Rat | valproic acid | affects expression | ISO | Xrn2 (Mus musculus) | 6480464 | Valproic Acid affects the expression of XRN2 mRNA | CTD | PMID:17963808 | Xrn2 | Rat | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of XRN2 mRNA | CTD | PMID:20566332 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















